_:n8160662df3a844ca96da9dc53c77a211xb3
<http://schema.org/url>
<https://www.cmlviz.com/stocks/GILD/news/b/2022/08/22/gilead-announces-first-global-regulatory-approval-of-sunlenca-lenacapavir-the-only-twice-yearly-hiv-treatment-option>